Editor's Note The National Institutes of Health (NIH) on May 14 announced that it is enrolling adults with mild to moderate COVID-19 in a study of treatment with hydroxychloroquine and azithromycin. The Phase 2b trial is enrolling around 2,000 adults across the US. Participants must have confirmed infection with SARS-CoV-2…

Read More

Editor's Note As states begin to ease restrictions imposed by COVID-19, physicians, nurse leaders, and administrators face a momentous challenge in resuming elective surgical procedures. Cincinnati Children’s Hospital Medical Center developed a model that made best use of available data (eg, case logs, forecasts, etc). Adoption of an agile methodology—a…

Read More

Editor's Note The Centers for Disease Control and Prevention on May 12 posted updated point-of-care (POC) testing biosafety guidelines for COVID-19. The update includes guidance for: use of instruments in a location associated with a current Clinical Laboratory Improvement Amendments certificate site- and activity-specific risk assessment proper staff training adherence…

Read More

Editor's Note While responding to demands of the COVID-19 pandemic, perioperative leaders also are busy preparing staff and departments for life after the initial shock subsides. Chief among their preparations are strategies to address the increased demand for surgery because of postponement of elective and nonessential surgical procedures. The sterile…

Read More

Editor's Note On May 12, California's Governor Gavin Newsom announced that California pharmacists will be allowed to collect specimens and order COVID-19 tests. Specimens will be are processed at public health, university, or commercial labs. The move is an effort to increase the state’s testing capacity as it modifies its…

Read More

Editor's Note This article from Houston Methodist Hospital and Texas A&M University researchers shares the lessons learned by an interdisciplinary team of ICU healthcare providers and their experiences of occupational fatigue and burnout as a result of the COVID-19 pandemic. The researchers documented four major areas of stress with the…

Read More

Editor's Note The Food & Drug Administration on May 11 took new actions to accelerate the development of novel prevention and treatment options for COVID-19. The agency is providing guidance documents to make the process for submitting applications to initiate studies for new drugs and biological products more efficient. The…

Read More

Editor's Note The University of Kentucky (UK) announced May 11 that researchers have begun antibody testing that will help to understand what immunity to COVID-19 really means. Several research labs within the UK College of Medicine and Pharmacy will be testing antibodies of recovered COVID-19 patients to see how long…

Read More

Editor's Note In this study, researchers at the Massachusetts General Hospital, Boston; King’s College, London; and health science company Zoe Global, Accra, Ghana; developed an artificial intelligence (AI) diagnostic that can predict whether someone is likely to have COVID-19 based on their symptoms. The researchers analyzed data from 2,618,862 people…

Read More

Editor's Note The May 8 Wall Street Journal reports that Atul Gawande, MD, is stepping away from the day-to-day operations of  Haven—the Amazon, JPMorgan, Berkshire Hathaway healthcare venture. Instead Dr Gawande will be chairman of the joint venture so he can focus more on policy and advocacy work, particularly related…

Read More